These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 23455206

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Synthesis, characterization and biological screening of N-substituted derivatives of 5-benzyl-1,3,4-oxadiazole-2yl-2"-sulfanyl acetamide.
    Siddiqui SZ, Rehman A, Abbasi MA, Abbas N, Khan KM, Ashraf M, Ejaz SA.
    Pak J Pharm Sci; 2013 May; 26(3):455-63. PubMed ID: 23625417
    [Abstract] [Full Text] [Related]

  • 3. Synthesis of some new biologically active N-substituted-2''- [(phenylsulfonyl)(piperidin-1-yl)amino]acetamide derivatives.
    Khalid H, Rehman AU, Abbasi MA, Siddiqui SZ, Malik A, Ashraf M, Ahmad I, Ejaz SA.
    Pak J Pharm Sci; 2014 May; 27(3):517-24. PubMed ID: 24811811
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Synthesis of novel 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(substituted/-nonsubstituted benzal)hydrazone derivatives and acetylcholinesterase and butyrylcholinesterase inhibitory activities in vitro.
    Utku S, Gökçe M, Orhan I, Sahin MF.
    Arzneimittelforschung; 2011 May; 61(1):1-7. PubMed ID: 21355440
    [Abstract] [Full Text] [Related]

  • 7. Synthesis of biologically active O-substituted derivatives of 1-[(3, 5-dichloro-2-hydroxyphenyl)sulfonyl]piperidine.
    Khalid H, Rehman A, Abbasi MA, Khan KM, Ashraf M, Ahmad I, Ejaz SA.
    Pak J Pharm Sci; 2013 May; 26(3):479-85. PubMed ID: 23625420
    [Abstract] [Full Text] [Related]

  • 8. Synthesis of 2-{(5-phenyl-1,3,4-Oxadiazol-2-yl)sulfanyl}-N-substituted acetamides as potential antimicrobial and hemolytic agents.
    Rehman AU, Abbasi MA, Siddiqui SZ, Ahmad I, Shahid M, Subhani Z.
    Pak J Pharm Sci; 2016 May; 29(3):801-9. PubMed ID: 27166551
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis, spectral characterization and enzyme inhibition studies of different chlorinated sulfonamides.
    Rehman AU, Abbasi MA, Rasool S, Ashraf M, Ejaz SA, Hassan R, Khalid N.
    Pak J Pharm Sci; 2014 Nov; 27(6):1739-45. PubMed ID: 25362587
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis and biological evaluation of 5-benzylidenerhodanine-3-acetic acid derivatives as AChE and 15-LOX inhibitors.
    Shafii N, Khoobi M, Amini M, Sakhteman A, Nadri H, Moradi A, Emami S, Saeedian Moghadam E, Foroumadi A, Shafiee A.
    J Enzyme Inhib Med Chem; 2015 Jun; 30(3):389-95. PubMed ID: 26095345
    [Abstract] [Full Text] [Related]

  • 16. Synthesis, biological screening and molecular docking studies of some ethylated sulfonamides having 1,4-Benzodioxane moiety.
    Irshad M, Abbasi MA, Rehman AR, Siddiqui SZ, Ali MS, Ashraf M, Ismail T, Ahmad I, Hassan S, Lodhi MA, Jamal SB.
    Pak J Pharm Sci; 2016 Nov; 29(6):1913-1925. PubMed ID: 28375106
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and antibacterial activity of various substituted oxadiazole derivatives.
    Kaur H, Kumar S, Verma RS, Garg A, Saxena KK, Lata S, Kumar A.
    Arch Pharm (Weinheim); 2011 Jul; 344(7):466-73. PubMed ID: 21500249
    [Abstract] [Full Text] [Related]

  • 18. Synthesis, enzyme inhibition and molecular docking studies of 1-Arylsulfonyl-4-phenylpiperazine derivatives.
    Abbasi MA, Anwar A, Rehman A, Siddiqui SZ, Rubab K, Shah SAA, Lodhi MA, Khan FA, Ashraf M, Alam U.
    Pak J Pharm Sci; 2017 Sep; 30(5):1715-1724. PubMed ID: 29084694
    [Abstract] [Full Text] [Related]

  • 19. Synthesis, SAR, and series evolution of novel oxadiazole-containing 5-lipoxygenase activating protein inhibitors: discovery of 2-[4-(3-{(r)-1-[4-(2-amino-pyrimidin-5-yl)-phenyl]-1-cyclopropyl-ethyl}-[1,2,4]oxadiazol-5-yl)-pyrazol-1-yl]-N,N-dimethyl-acetamide (BI 665915).
    Takahashi H, Riether D, Bartolozzi A, Bosanac T, Berger V, Binetti R, Broadwater J, Chen Z, Crux R, De Lombaert S, Dave R, Dines JA, Fadra-Khan T, Flegg A, Garrigou M, Hao MH, Huber J, Hutzler JM, Kerr S, Kotey A, Liu W, Lo HY, Loke PL, Mahaney PE, Morwick TM, Napier S, Olague A, Pack E, Padyana AK, Thomson DS, Tye H, Wu L, Zindell RM, Abeywardane A, Simpson T.
    J Med Chem; 2015 Feb 26; 58(4):1669-90. PubMed ID: 25671290
    [Abstract] [Full Text] [Related]

  • 20. Synthesis, characterization and biological activity of some new 1,3,4-oxadiazole bearing 2-flouro-4-methoxy phenyl moiety.
    Chandrakantha B, Shetty P, Nambiyar V, Isloor N, Isloor AM.
    Eur J Med Chem; 2010 Mar 26; 45(3):1206-10. PubMed ID: 20004043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.